Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infanrix-IPV+Hib Immunogenicity and Safety in Korean Infants
NCT01309646Phase 3Completed
- Sponsor
- GSK
- Start
- Mar 2011
- Primary completion
- Feb 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of diphtheria + tetanus + acellular pertussis + inactivated poliomyelitis + Haemophilus influenzae type b vaccine in diphtheria, Tetanus, pertussis, poliomyelitis, Haemophilus influenzae type b infection (Hib), sponsored by GSK. Started Mar 2011; status: completed.
02
Drugs
diphtheria + tetanus + acellular pertussis + inactivated poliomyelitis + Haemophilus influenzae type b vaccine
03
Conditions
diphtheriaTetanuspertussispoliomyelitisHaemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT01309646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01309646.